EUVIMEDEUVIMED entdecken
Validierungsstudie

Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics

Ning Wang, Shihui Qu, Weiwei Kong, Qian Hua, Zhihui Hong, Zengli Liu, Yizhen Shi

Annals of Nuclear Medicine · 2024-09 · 38 (9) · 734-743

DOI: 10.1007/s12149-024-01942-4 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Annals of Nuclear Medicine, online erschienen am 01.06.2024. Verfasst von Ning Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Bone Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: Innovative Research Group Project of the National Natural Science Foundation of China, Open Program of NHC Key Laboratory of Nuclear Medicine and Jiangsu Key Laboratory of Molecular Nuclear Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: To establish and validate novel predictive models for predicting bone metastasis (BM) in newly diagnosed prostate adenocarcinoma (PCa) via single-photon emission computed tomography radiomics. METHOD: In a retrospective review of the clinical single-photon emission computed tomography (SPECT) database, 176 patients (training set: n = 140; validation set: n = 36) who underwent SPECT/CT imaging and were histologically confirmed to have newly diagnosed PCa from June 2016 to June 2022 were enrolled. Radiomic features were extracted from the region of interest (ROI) in a targeted lesion in each patient. Clinical features, including age, total prostate-specific antigen (t-PSA), and Gleason grades, were included. Statistical tests were then employed to eliminate irrelevant and redundant features. Finally, four types of optimized models were constructed for the prediction. Furthermore, fivefold cross-validation was applied to obtain sensitivity, specificity, accuracy, and area under the curve (AUC) for performance evaluation. The clinical usefulness of the multivariate models was estimated through decision curve analysis (DCA). RESULTS: A radiomics signature consisting of 27 selected features which were obtained by radiomics' LASSO treatment was significantly correlated with bone status (P < 0.01 for both training and validation sets). Collectively, the models showed good predictive efficiency. The AUC values ranged from 0.87 to 0.98 in four models. The AUC values of the human experts were 0.655 and 0.872 in the training and validation groups, respectively. Most radiomic models showed better diagnostic accuracy than human experts in the training and validation groups. DCA also demonstrated the superiority of the radiomics models compared to human experts. CONCLUSION: Radiomics models are superior to humans in differentiating between benign bone and prostate cancer bone metastases; it can be used to facilitate personalized prediction of BM in newly diagnosed PCa patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBone NeoplasmsAdenocarcinomaHumansMaleAgedRetrospective StudiesMiddle AgedImage Processing, Computer-AssistedTomography, Emission-Computed, Single-PhotonAged, 80 and overSingle Photon Emission Computed Tomography Computed TomographyRadiomics

Stichwörter der Autor:innen

Bone metastasisProstate adenocarcinomaRadiomicsSingle-photon emission computed tomography

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai, 201318, China.
  • Department of Nuclear Medicine, the Second Affiliated Hospital of Soochow University, 215004, Jiangsu, Suzhou, China.
  • Department of Nuclear Medicine, the Second Affiliated Hospital of Soochow University, 215004, Jiangsu, Suzhou, China. shiyizhen@suda.edu.cn.

Förderung

  • Innovative Research Group Project of the National Natural Science Foundation of China
  • Open Program of NHC Key Laboratory of Nuclear Medicine and Jiangsu Key Laboratory of Molecular Nuclear Medicine

Zitieren

APA

Wang, N., Qu, S., Kong, W., Hua, Q., Hong, Z., Liu, Z., & Shi, Y. (2024). Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics. Annals of Nuclear Medicine, 38(9), 734-743. https://doi.org/10.1007/s12149-024-01942-4

Vancouver

Wang N, Qu S, Kong W, Hua Q, Hong Z, Liu Z, et al. Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics. Annals of Nuclear Medicine. 2024;38(9):734-743. doi:10.1007/s12149-024-01942-4

BibTeX
@article{Wang2024,
  author = {Wang, Ning and Qu, Shihui and Kong, Weiwei and Hua, Qian and Hong, Zhihui and Liu, Zengli and Shi, Yizhen},
  title = {Establishment and validation of novel predictive models to predict bone metastasis in newly diagnosed prostate adenocarcinoma based on single-photon emission computed tomography radiomics},
  journal = {Annals of Nuclear Medicine},
  year = {2024},
  volume = {38},
  number = {9},
  pages = {734--743},
  doi = {10.1007/s12149-024-01942-4}
}
Kostenlos starten →